Lv1
20 积分 2024-09-06 加入
Emerging micro- and nanotechnology based synthetic approaches for insulin delivery
8小时前
已完结
Efficacy and Safety of Biosimilar SAR342434 Insulin Lispro in Adults with Type 1 Diabetes Also Using Insulin Glargine—SORELLA 1 Study
2个月前
已完结
Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate
5个月前
已完结
Rapid and Long-Acting Analogues as an Approach to Improve Insulin Therapy: An Evidence-Based Medicine Assessment
6个月前
已完结
Accelerated Pharmacokinetics and Glucodynamics of Prandial Insulins Injected With Recombinant Human Hyaluronidase
7个月前
已完结
Pharmacokinetic and pharmacodynamic bioequivalence of Gan & Lee insulin analogues aspart (rapilin®), lispro (prandilin®) and glargine (basalin®) with EU‐ und US‐sourced reference insulins
7个月前
已完结
Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase
10个月前
已完结
Inhibitors of Xanthine Oxidase: Scaffold Diversity and Structure‐Based Drug Design
10个月前
已完结
Xanthine Oxidoreductase Inhibitors
10个月前
已完结
Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat
10个月前
已完结
皖公网安备34019202002308
